Pharma API Manufacturer

[pharmaapimanufacturer]

Dr. Reddy’s Laboratories is a leading Granisteron API manufacturer and supplier with global reach. Our Granisteron API (CAS 109889-09-0) is intended for antiemetic therapy, used to prevent nausea and vomiting linked to chemotherapy, radiation, and post-operative treatments. We employ advanced synthetic API technology under GMP guidelines, and our product is available under regulatory filings including US DMF, EU DMF, and Korea DMF.

As experts in complex API development, Dr. Reddy’s combines deep capabilities in R&D, regulatory affairs, and supply chain management to ensure quality, compliance, and scalable supply. Whether you are a pharmaceutical innovator or generic manufacturer, our Granisteron API supports your goals with reliable delivery, regulatory support, and technical expertise.

[pharmaapimanufacturer]

Meet Dr. Reddy's API team at CPHI China 2025, June 24–26 at SNIEC, Shanghai. Explore our extensive API portfolio and regulatory expertise. M

[pharmaapimanufacturer]

Dr. Reddy’s API team highlights innovation and global collaboration in CPhI Japan 2025 news, reinforcing commitment to quality pharmaceutica

[pharmaapimanufacturer]

API manufacturing companies are transforming with digital technologies like AI, IoT, cloud, and automation to enhance efficiency, regulatory

[pharmaapimanufacturer]

Discover how Indian API pharma companies are strengthening global drug supply chains through innovation, scale, regulatory compliance, and c

[pharmaapimanufacturer]

Dr. Reddy’s introduces Lumateperone Tosylate API, a next-gen antipsychotic for treating schizophrenia and bipolar depression. Backed by regu

[pharmaapimanufacturer]

世界のトップAPIメーカーおよびサプライヤー企業から、胃腸疾患（GI）の下にあるOral Solid/Capsules, Suspensionおよび合成を使用してエソメプラゾールマグネシウム三水和物 API（CAS No. 217087-09-7）の見積もりをオンラインで入手して

[pharmaapimanufacturer]

Obtenha uma cotação de Gatifloxacina (Anidra) API (CAS No. 112811-59-3) com Solution/Drops e Sintético em Anti-Infecciosa on -line da princi

[pharmaapimanufacturer]

Obtenga una cita de Ketorolaco Trometamina API (CAS No. 74103-07-4) con Sólidos orales, Injectable, Nasal, Oftálmico y Sintético en Tratamie

[pharmaapimanufacturer]

从全球顶级 API 制造商和供应商公司在线获取心血管的下的沙库巴曲缬沙坦钠 API（CAS No. 936623-90-4）和Oral Solid/Tablets和合成的报价。

[pharmaapimanufacturer]

Get a quote of Glimepiride API (CAS No. 93479-97-1) with Oral Solid/Tablets dose form & Synthetic API technology under Anti-Diabetic Therape

[pharmaapimanufacturer]

Dr. Reddy’s Fosaprepitant API (CAS No. 265121-04-8) is a synthetic, injectable-grade active pharmaceutical ingredient within the anti-cancer/antiemetic therapeutic category, expertly designed to combat chemotherapy-induced nausea and vomiting. This API, approved by the US FDA, EMA (2008), and PMDA (2011), represents a high-demand specialty molecule—estimated globally at approximately 500 kg annually as of late 2020. Leveraging their deep expertise in R&D, regulatory compliance, and global supply chain management, Dr. Reddy’s offers a stable amorphous form of Fosaprepitant that aligns with stringent formulation and regulatory specifications. This positioning underscores Dr. Reddy’s commitment to delivering reliable, high-quality APIs that enable pharmaceutical companies to develop injectable antiemetic therapies with confidence.

[pharmaapimanufacturer]

Dr. Reddy’s offers Fezolinetant API (CAS 1629229‑37‑3), a synthetic active pharmaceutical ingredient under development in the gynecology therapeutic category. Designed for oral solid dosage form formulations, this API supports non‑hormonal treatment aimed at reducing moderate to severe vasomotor symptoms associated with menopause. As a selective neurokinin‑3 (NK₃) receptor antagonist, Fezolinetant works by modulating thermoregulatory neural pathways to alleviate hot flashes and night sweats. Currently in development, this API is part of Dr. Reddy’s growing portfolio of over 200 molecules backed by global compliance and regulatory expertise – ideal for generics, formulation developers, and clinical sponsors seeking quality-assured menopausal therapy APIs.

[pharmaapimanufacturer]

  Meet Dr. Reddy's API Team during CPHI Korea 2025 from August 26 - 28, 2025 in COEX in Seoul, South

[pharmaapimanufacturer]

On October 23, 2021, Prime Minister Narendra Modi met Indian COVID-19 pharma leaders, including Dr. Reddy's to discuss about the various is

[pharmaapimanufacturer]

The active pharmaceutical ingredient industry is undergoing a transformative shift. As global demand for high-quality medicines continues to

[pharmaapimanufacturer]

In the pharmaceutical industry, the term API pharma refers to the Active Pharmaceutical Ingredient—the biologically active component in a dr